Project Details
Project Description
The Donor wishes to give to the University $40,000 to support A Phase 2 Randomised Controlled Trial of Sodium Selenate as a Disease Modifying Treatment for Probable Progressive Supranuclear Palsy
| Status | Active |
|---|---|
| Effective start/end date | 30/09/21 → 30/09/25 |
Keywords
- Progressive Supranuclear Palsy (PSP)
- Sodium selenate
- Neuroscience
- Personal donation